Owner Idenix Pharmaceuticals, Inc.

Inventors Dousson, Cyril B.; Dukhan, David; Parsy, Christophe Claude; Pierra, Claire; Alexandre, Francois-Rene; Brandt, Guillaume; Da Costa, Daniel; Rahali, Houcine; Paparin, JeanLaurent; Derock, Michel; Convard, Thierry; Surleraux, Dominique

Agent HENRY HUGHES LIMITED

Pub. Number AU-A-2010330862

PCT Pub. Number WO2011/075615

Priority 61/371,634 06.08.10 US; 61/288,207 18.12.09 US

Filing date 17 December 2010

Wipo publication date 23 June 2011

C07D 487/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/381 - having five-membered rings

A61K 31/424 - condensed with heterocyclic ring systems, e.g. clavulanic acid

A61K 31/429 - condensed with heterocyclic ring systems

A61P 31/12 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07D 491/048 Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

C07D 495/04 Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

C07D 498/04 Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 513/04 Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or